Clinical Trials Directory

Trials / Completed

CompletedNCT02916134

Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
186 (actual)
Sponsor
Beaumont Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare antibiotic treatment versus surgery for patients with uncomplicated appendicitis.

Detailed description

The study will include patients aged 16 and over, with a first admission with right iliac fossa pain and a raised white cell count or C-reactive protein. Patients will be randomised electronically in a 1:1 ratio either to undergo emergency appendectomy or to receive intravenous antibiotics as an inpatient, until clinical and biochemical improvement is observed, followed by outpatient oral antibiotics. Those who have surgery will have 3 post-operative doses of intravenous antibiotics, unless perforation was identified at the time of surgery, in which case, microbiology will be contacted to advise regarding antibiotic choice and duration. Follow-up by telephone interview will be at 1 week, 1, 3 and 12-month intervals.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic +/- Open AppendicectomyLaparoscopic +/- open appendicectomy , with antibiotics at induction (intravenous co-amoxiclav 1.2g, or if penicillin allergic, cefuroxime 1.5g + metronidazole 500mg ), followed by 3 further intravenous doses of the same antibiotic. If a perforation is identified at the time of surgery, microbiology will be contacted regarding choice and duration of of antibiotic.
DRUGAntibiotic treatmentIntravenous co-amoxiclav 1.2g three times daily, then 625mg, orally three times daily. If penicillin allergic, intravenous cefuroxime 1.5g three times daily + metronidazole 500mg three times daily, then oral cefuroxime 500mg twice daily + oral metronidazole 400mg three times daily. The patient will receive inpatient intravenous antibiotics until sufficient clinical improvement is noted by the surgical team, who will be assessing the patient twice daily. After discharge the patient will receive 5 further days of oral antibiotics.

Timeline

Start date
2016-09-12
Primary completion
2019-12-08
Completion
2019-12-08
First posted
2016-09-27
Last updated
2020-07-13

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02916134. Inclusion in this directory is not an endorsement.